Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anouk Dev

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Journal of Gastroenterology and Hepatology|December 16, 2011
Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: a multicenter clinical experienceDilip Ratnam, Anouk Dev, Tin Nguyen, et al.
Scandinavian Journal of Gastroenterology|January 24, 2015
Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian studyIlana Gory, Michael Fink, Sally Bell, et al.
Journal of Hepatology|May 1, 2018
Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis CStephen Bloom, William Kemp, Amanda Nicoll, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2013
Nucleotide oligomerization domain 1 enhances IFN-γ signaling in gastric epithelial cells during Helicobacter pylori infection and exacerbates disease severityCody C Allison, Jonathan Ferrand, Louise McLeod, et al.
Journal of Gastrointestinal Cancer|September 9, 2020
SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study)Ryan D Hirsch, Chris Mills, Rohit Sawhney, et al.
Journal of Gastrointestinal Cancer|May 31, 2022
Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysisGauri Mishra, Ammar Majeed, Anouk Dev, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 12, 2008
Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis CKeyur Patel, David R Nelson, Don C Rockey, et al.
The Medical Journal of Australia|January 26, 2020
Survival of patients with ruptured and non-ruptured hepatocellular carcinomaNatassia P Tan, Ammar Majeed, Stuart K Roberts, et al.
Scandinavian Journal of Gastroenterology|November 6, 2018
Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survivalStuart K Roberts, Alessia Gazzola, John Lubel, et al.
Journal of Gastroenterology and Hepatology|November 7, 2019
Increasing prevalence of primary biliary cholangitis in Victoria, AustraliaJanine French, Ingrid van der Mei, Steve Simpson, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Journal of Gastroenterology and Hepatology|December 16, 2011
Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: a multicenter clinical experienceDilip Ratnam, Anouk Dev, Tin Nguyen, et al.
Scandinavian Journal of Gastroenterology|January 24, 2015
Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian studyIlana Gory, Michael Fink, Sally Bell, et al.
Journal of Hepatology|May 1, 2018
Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis CStephen Bloom, William Kemp, Amanda Nicoll, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2013
Nucleotide oligomerization domain 1 enhances IFN-γ signaling in gastric epithelial cells during Helicobacter pylori infection and exacerbates disease severityCody C Allison, Jonathan Ferrand, Louise McLeod, et al.
Journal of Gastrointestinal Cancer|September 9, 2020
SIRT Compared with DEB-TACE for Hepatocellular Carcinoma: a Real-world Study (the SITAR Study)Ryan D Hirsch, Chris Mills, Rohit Sawhney, et al.
Journal of Gastrointestinal Cancer|May 31, 2022
Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysisGauri Mishra, Ammar Majeed, Anouk Dev, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 12, 2008
Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis CKeyur Patel, David R Nelson, Don C Rockey, et al.
The Medical Journal of Australia|January 26, 2020
Survival of patients with ruptured and non-ruptured hepatocellular carcinomaNatassia P Tan, Ammar Majeed, Stuart K Roberts, et al.
Scandinavian Journal of Gastroenterology|November 6, 2018
Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survivalStuart K Roberts, Alessia Gazzola, John Lubel, et al.
Journal of Gastroenterology and Hepatology|November 7, 2019
Increasing prevalence of primary biliary cholangitis in Victoria, AustraliaJanine French, Ingrid van der Mei, Steve Simpson, et al.
Pageof 7